OXCT1 and diabetes mellitus: Therefore, to simulate the metabolic effect of targeting OXCT1, we exploited the chiral property of βHB by treating the cells with the metabolically inactive enantiomer S-βHB (5 mM) at a dose range of natural ketosis without causing severe ketoacidosis (30, 31).